Amala Kompella

This inventor holds 10 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Natco Pharma Limited. Active years: 2011-2020.

USPTO Granted Patents = 10 (Patent Applications = 4)

% Patents Active = 40.0

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 22(Granted Patents)

Location History:

Banjara Hills, IN (2016)
Hyderabad, IN (2011 - 2020)

Company Filing History:

10 out of 51

Natco Pharma Limited

patents

Years Active: 2011-2020

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10870650 - Process for the preparation of amorphous idelalisib (2020-12-22),

2. 10047088 - 1H-1,8-naphthyridin-2-ones as anti proliferative compounds (2018-08-14),

3. 9765072 - 1H-1,8-naphthyridin-2ones as anti proliferative compounds (2017-09-19),

4. 9440959 - Process for the preparation of nilotinib (2016-09-13),

5. 9061028 - Process for the preparation of Nilotinib (2015-06-23),

6. 8735415 - Acid addition salts of (3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide (2014-05-27),

7. 8183253 - Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase (2012-05-22),

8. 8067422 - Crystal form of phenylamino pyrimidine derivatives (2011-11-29),

9. 7939541 - Intermediates and a process employing the intermediates for the preparation of (3-trifluoromethylsulfonyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide (2011-05-10),

10. 7910598 - Phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase (2011-03-22),

Title: Amala Kompella: Innovator in Pharmaceutical Chemistry

Introduction

Amala Kompella is a prominent inventor based in Hyderabad, Telangana, India. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds and processes. With a total of 10 patents to her name, her work has had a substantial impact on therapeutic treatments.

Latest Patents

One of her latest patents is titled "Process for the preparation of amorphous idelalisib." This invention relates to a method for producing a stable and pure amorphous form of Idelalisib. The process is noted for being simple, economical, and efficient, making it suitable for industrial scale-up while achieving a high degree of chromatographic purity. Another significant patent is for "1H-1,8-naphthyridin-2-ones as anti-proliferative compounds." This invention introduces novel antiproliferative 1H-1,8-naphthyridin-2-ones, which can be used in therapeutic treatments for disorders related to the inhibition of tyrosine kinases in warm-blooded animals. These compounds are particularly valuable as they can overcome imatinib-induced drug resistance.

Career Highlights

Amala Kompella is currently associated with Natco Pharma Limited, where she continues to innovate and contribute to the pharmaceutical industry. Her expertise in developing effective therapeutic compounds has positioned her as a key player in her field.

Collaborations

Amala has collaborated with notable colleagues, including Sreenivas Rachakonda and Venkaiah Chowdary Nannapaneni, to further advance her research and development efforts.

Conclusion

Amala Kompella's work in pharmaceutical chemistry exemplifies the spirit of innovation and dedication to improving healthcare through her inventions. Her contributions continue to influence the industry and pave the way for future advancements.